New drug combo targets aggressive prostate cancer spread
NCT ID NCT03821792
Summary
This study tests whether a combination of three medications can help control advanced prostate cancer that has spread to other parts of the body. The trial involves 60 men with high-risk prostate cancer who haven't had extensive prior hormone treatment. Researchers will give participants three drugs daily for one year to block the hormones that fuel prostate cancer growth, while also checking if certain tumor markers can predict who will respond best.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.